semaglutide or tirzepatide less side effects vs. Semaglutide: Which Has Fewer Effects? Tirzepatide vs. Semaglutide for Weight

After a year of treatment, people who received lixisenatide showed better outcomes in their movement symptoms compared to those who received a placebo

Every four weeks, the dose is gradually escalated (to 0.5 mg, 1.0 mg, 1.7 mg, and finally the maintenance dose of 2.4 mg per week) until the patient reaches their target clinical maintenance level

## Availability Status: March 2026 - **FDA status:** Phase 3 clinical trials ongoing - **Expected approval timeline:** Potentially 2026-2027 - **Brand availability:** None yet - **Current access:** Compounding pharmacies (503A/503B) with valid prescription For a detailed breakdown of [retatrutide's FDA approval status and projected timeline](/guides/retatrutide-fda-approval-2026-timeline-status), see our dedicated tracker the date brand pricing becomes available depends directly on when retatrutide clears FDA review

Recognition of Aspergillus fumigatus hyphae by human plasmacytoid dendritic cells is mediated by dectin-2 and results in formation of extracellular traps

Advise the patient to read the FDA-approved patient labeling (Patient Information)

Finally, preoperative gastric ultrasound is here and now widely available for decision making